Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 454 | 899 | 731 | 662 | 467 |
| Cost of Goods | N/A | N/A | 579 | 633 | 487 |
| Gross Profit | 454 | 899 | 152 | 29 | -20 |
| Operating Expenses | 2,681 | 2,745 | 5,083 | 4,292 | 4,810 |
| Operating Income | -2,227 | -1,846 | -4,352 | -3,630 | -4,343 |
| Interest Expense | 513 | 444 | 423 | 446 | 474 |
| Other Income | 1,344 | 5 | 366 | -210 | 10 |
| Pre-tax Income | -1,396 | -2,285 | -4,409 | -4,286 | -4,807 |
| Net Income Continuous | -1,396 | -2,285 | -4,409 | -4,286 | -4,807 |
| Net Income Discontinuous | -934 | -1,374 | N/A | N/A | N/A |
| Net Income | $-2,330 | $-3,659 | $-4,409 | $-4,286 | $-4,807 |
| EPS Basic Total Ops | -10,356.07 | -11,120.69 | -13,680.66 | -91,828.77 | -26,049.48 |
| EPS Basic Continuous Ops | -8,347.08 | -6,945.28 | -13,730.05 | -68,863.92 | -26,119.52 |
| EPS Basic Discontinuous Ops | -2,009.00 | -4,175.41 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -10,356.07 | -11,120.69 | -13,680.66 | -91,828.77 | -26,049.48 |
| EPS Diluted Continuous Ops | -8,347.08 | -6,945.28 | -13,730.05 | -68,863.92 | -26,119.52 |
| EPS Diluted Discontinuous Ops | -2,009.00 | -4,175.41 | N/A | N/A | N/A |
| EBITDA(a) | $-1,566 | $-1,261 | $-3,750 | $-2,970 | $-3,615 |